It’s probably worth hanging in there a little longer ...
Yes, the SP is in languishing
Yes, the company communications could be more regular and often ‘clearer’.
Yes, ‘bio’ trials take an awful long time
But ...It’s hard to believe that the IMU Team is not seeing some amazing things in the trials.
They have just spent an enormous amount of time, effort and money to ‘lock up’ the IP in two major markets ... China and India.
Ask yourself if this makes sense ... unless they see huge value in this IP !
IMO, it’s still worth hanging in there a little longer.
All opinion, of course.
Ann: Imugene Granted India Patent for Oncolytic Virotherapy CF33, page-11
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
-0.001(7.14%) |
Mkt cap ! $97.07M | |||
| Open | High | Low | Value | Volume |
| 1.3¢ | 1.3¢ | 1.2¢ | $179.4K | 14.42M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 52 | 15731879 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 3463196 | 20 |
View Market Depth
| Last trade - 16.10pm 23/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |